TWST TWIST BIOSCIENCE
Health Care · Russell 2000
Next earnings: Thu 12 Nov 2026 · before market open
What 15 analyst firms say about TWIST BIOSCIENCE: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
15 rated views · 16 analyst/firm records · 15 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8029
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8033
Recent analyst activity · last 90 days
Our tracked history has 13 reports on TWST from 10 analyst firms in the last 90 days (15 firms in the past year).
Comparing each firm's latest target with its previous one: 5 raised their price target, 2 left it unchanged and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Cowen raised its target from $89.00 (set 15 Jun 2026) to $190.00 on 13 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Baird | Catherine Ramsey Schulte | Buy | 4 Aug 2026 | Conflicting reports · excluded |
| Barclays | Luke Sergott | Buy | 7 Oct 2026 | 215.00 USD |
| Bws Financial | Hamed Khorsand | Sell | 18 Sep 2026 | 45.00 USD |
| Canaccord Genuity | Kyle Mikson | Buy | 12 Oct 2026 | 205.00 USD |
| Evercore ISI | Vijay Kumar | Hold | 5 Oct 2026 | 150.00 USD |
| Guggenheim | Subbu Nambi | Buy | 1 Oct 2026 | 212.00 USD |
| Jefferies | David Stanton | Hold | 8 Oct 2026 | 150.00 USD |
| Jefferies | Matthew Stanton | Hold | 8 Oct 2026 | 150.00 USD |
| Leerink Partners | Puneet Souda | Buy | 29 Sep 2026 | 190.00 USD |
| Piper Sandler | David Westenberg | Buy | 5 Aug 2026 | 115.00 USD |
| Stephens | Steven Etoch | Buy | 20 Jul 2026 | 115.00 USD |
| TD Cowen | Brendan Smith | Buy | 13 Oct 2026 | 190.00 USD |
| UBS | Doug Schenkel | Hold | 9 Sep 2026 | Conflicting reports · excluded |
| Weiss Ratings | Unnamed analyst | — | 21 Sep 2026 | — |
| William Blair | Matt Larew | Buy | 26 May 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 04:05 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.